Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Global Market Insights

CRWV Stock Today: March 22 — 57% Off Highs as $30B Capex Tests Margins

March 22, 2026
5 min read
Share with:

CRWV stock is back in focus after a 57% slide from its 52-week high of $187 to $80.66. The debate is clear: a $66.8B backlog and 2025 revenue of $5.1B versus a $30B capex plan in 2026 that could pressure margins. Analysts skew to Moderate Buy, while one composite rating sits at D+. For Hong Kong investors, AI infrastructure demand is strong, but cash flow and leverage matter. The ticker CRWV trades in USD, so plan for FX and liquidity when sizing entries.

Valuation Versus Backlog: What the Drawdown Signals

CRWV stock trades at $80.66 with a market cap of $42.9B. TTM price-to-sales is 7.97 and EV/sales is 10.28, rich for a loss-making name. The 57% drop compresses multiples but still prices in growth. With a $66.8B backlog against 2025 revenue of $5.1B, conversion speed is key. EPS is -2.81 and price-to-book is 10.15, so profitability must inflect.

Sponsored

Gross margin is strong at 71.7%, but operating margin is -0.9% and free cash flow per share is -16.67. Capex-to-revenue sits at 2.01x and capex-to-operating cash flow at 3.37x, pointing to heavy investment. Debt-to-equity is 4.54 with a current ratio of 0.46 and negative interest coverage, underscoring financing risk as capex 2026 ramps.

Coverage shows 13 Buys, 10 Holds, and 3 Sells, broadly a Moderate Buy tilt. A composite stock grade reads B+ with a Buy suggestion, but a separate D+ fundamental rating flags risk. Near-term model targets show $83.04 monthly and $108.40 yearly. See overview and sentiment context here: source.

Capex 2026: Margin Test Against AI Infrastructure Demand

The planned $30B spend by 2026 supports GPU data center scale but lifts depreciation, interest, and working capital needs. With working capital at -$8.95B and DSO at 225 days, cash timing matters. Execution that lifts utilization and billing cadence is crucial if CRWV stock is to re-rate without further dilution or leverage.

Core AI workloads in training and inference continue to expand, supporting the $66.8B backlog. Pricing and long-term contracts will decide the margin path as capacity comes online. Sector demand context remains constructive for infrastructure providers, though competitive intensity is rising. See industry demand trend highlights: source.

Watch booking-to-billing conversion, gross-to-operating margin spread, and free cash flow inflection as new sites ramp. Receivables days at 225 versus payables at 408 spotlight cash discipline. The next earnings update is due 13 May 2026. If guidance links capex to contracted returns, CRWV stock could earn multiple relief.

Today’s Setup: Price, Momentum, and Risk for HK Investors

Spot is $80.66 after trading between $78.78 and $81.60 today. RSI is 47.6, near neutral. ADX at 12.4 signals no strong trend. Price sits below the 50-day at $88.42 and the 200-day at $108.90. Bollinger mid-band is $82.49. This places CRWV stock in a consolidation zone where catalysts will likely drive breaks.

MACD histogram has turned positive at 0.53, with Stochastic %K at 63, hinting at a mild bullish bias. Keltner mid sits near $82.83, with Bollinger lower at $66.80 guiding downside risk. ATR is 6.52, suggesting wide intraday swings. For swing traders, a close above the 50-day would improve the upside case.

Consider staged entries to manage volatility, anchored to position size set in HKD terms while recognizing USD settlement. Use ATR-based stops and reassess if free cash flow trends do not improve as capex advances. CRWV stock is a growth-plus-execution idea, so align risk budgets with contract conversion, funding costs, and utilization updates.

Final Thoughts

CRWV stock offers a clear trade-off: a massive $66.8B backlog and strong AI infrastructure demand against negative earnings, tight liquidity, and a heavy $30B capex plan set for 2026. Valuation remains growth-weighted at 7.97x TTM sales and 10.28x EV/sales, so margin and cash flow inflection must follow. Technically, the setup is neutral with volatility elevated. For Hong Kong investors, size positions carefully in HKD terms, expect USD-based swings, and use staged adds tied to milestones. Key checkpoints include booking-to-billing conversion, operating margin improvement, and free cash flow trends. A constructive update at the 13 May 2026 earnings date could reset the risk-reward.

FAQs

Is CRWV stock attractive after a 57% drop from its high?

It is more interesting, not outright cheap. TTM price-to-sales is 7.97 and EV/sales is 10.28, which still price in growth. The $66.8B backlog supports revenue visibility, but losses and leverage remain. Upside needs margin expansion and free cash flow progress before valuation can rerate.

How will the $30B capex in 2026 affect margins and cash flow?

Near term, margins and free cash flow likely compress as depreciation, interest, and working capital needs rise. With capex-to-revenue at 2.01x and negative interest coverage, funding discipline is critical. If utilization scales and contracts convert quickly, operating leverage can offset pressure and improve cash generation.

What should Hong Kong investors watch before buying CRWV stock?

Focus on backlog conversion speed, operating margin trends, and free cash flow. Track debt metrics and any equity or debt raises tied to capex. Consider USD exposure and liquidity when sizing in HKD. The next earnings update on 13 May 2026 could clarify timelines and capital needs.

What are key technical levels and signals for CRWV stock now?

Price is below the 50-day at $88.42 and the 200-day at $108.90. The Bollinger mid-band at $82.49 acts as nearby resistance and the lower band near $66.80 as support. RSI is 47.6 and ADX is 12.4, suggesting a neutral, low-trend regime with an ATR of 6.52.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)